Anogenital dermatoses - Allergic and irritative causative factors. Analysis of IVDK 1 data and review of the literature;Anogenitaldermatosen - Allergische und irritative auslösefaktoren. Analyse von daten des IVDK 1 und literaturübersicht

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 12, 2005, Pages 979-986

  Kügler, Katrin ^a   Brinkmeier, Thomas ^a   Frosch, Peter J ^a   Uter, Wolfgang ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Anogenital dermatoses; Contact allergy; Contact dermatitis; Irritation; Patch tests

Indexed keywords

ALLERGEN; AMCINONIDE; AMERCHOL L 101; ANTIINFLAMMATORY AGENT; BENZOCAINE; BUFEXAMAC; CICLOPIROXOLAMINE; CINCHOCAINE; CLIOQUINOL; CLOTRIMAZOLE; CONTRACEPTIVE AGENT; CORTICOSTEROID; COSMETIC; CROCONAZOLE; GENTAMICIN; HEXYLRESORCINOL; HYDROCORTISONE BUTYRATE; IRRITANT AGENT; KETOCONAZOLE; LIDOCAINE; PROPOLIS; LOCAL ANESTHETIC AGENT;

ADULT; ALLERGY; ANOGENITAL DERMATOSIS; ANUS; ARTICLE; BALANITIS; FAKTU; FEMALE; GENITAL HERPES; GENITAL SYSTEM; HEAT; HUMAN; IRRITANT DERMATITIS; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALE; MECHANICAL STRESS; OCCLUSION; PATCH TEST; PROPHYLAXIS; SENSITIZATION; SKIN ALLERGY; SKIN DISEASE; ANUS DISEASE; CLINICAL TRIAL; COMORBIDITY; DERMATOLOGY; EPIDEMIOLOGY; FACTUAL DATABASE; GENITAL SYSTEM DISEASE; GERMANY; GYNECOLOGIC DISEASE; METHODOLOGY; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; STATISTICS;

ADULT; ANESTHETICS, LOCAL; ANUS DISEASES; BENZOCAINE; BUFEXAMAC; CAUSALITY; CLINICAL TRIALS; COMORBIDITY; DATABASES, FACTUAL; DERMATITIS, ALLERGIC CONTACT; DERMATOLOGY; DIBUCAINE; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SKIN DISEASES;

EID: 33644834890     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2005.05763.x     Document Type: Article

References (48)

1. Schnuch A. PAFS: population-adjusted frequency of sensitization. (I) Influence of sex and age. Contact Dermatitis 1996; 34: 377-382.
2. Uter W, Schnuch A, Geier J, Frosch PJ. Epidemiology of contact dermatitis. The information network of departments of dermatology (IVDK) in Germany. Eur J Dermatol 1998; 8: 36-40.
3. Schnuch A, Aberer W, Agathos M, Brasch J, Frosch PJ, Fuchs Th, Richter G. Leitlinie der Deutschen Dermatologischen Gesellschaft (DDG) zur Durchführung des Epikutantests mit Kontaktallergenen. Hautarzt 2003; 52: 864-866.
4. Wahlberg JE. Patch testing. In: Rycroft RJG, Menné T, Frosch PJ: Textbook of Contact Dermatitis. Berlin: Springer, 2001: 435-468.
5. Bauer A, Geier J, Elsner P. Allergic contact dermatitis in patients with anogenital complaints. The Journal of Reproductive Medicine 2000; 45: 649-654.
6. Geier J. Epikutantestung mit dem DKG-Analblock. Derm Beruf Umwelt 1995; 43: 81-82.
7. Wakelin SH, Smith H, White IR, Rycroft RJG, McFadden JP. A retrospective analysis of contact allergy to lanolin. Br J Dermatol 2001; 145: 28-31.
8. Lewis FM, Shah M, Gawkrodger DJ. Contact sensitivity in pruritus vulvae: patch test results and clinical outcome. Am J Contact Dermat 1997; 8: 137-140.
9. Goldsmith PC, Rycroft RJG, White IR, Ridley CM, Neill SM, McFadden JP. Contact sensitivity in women with anogenital dermatoses. Contact Dermatitis 1997; 36: 174-175.
10. Dooms-Gossens A, Verschaeve H, Degreef H, van Berendoncks J. Contact allergy to hydrocortisone and thixocortol pivalate: problems in the detetction of corticosteroid sensitivity. Contact Dermatitis 1986; 14: 94-102.
11. Guin JD. Contact sensitivity to topical corticosteroids. J Am Acad Dermatol 1984; 10: 773-782.
12. Reitamo S, Lauerma S, Stubb S, Käyhkö K, Visa K, Förström L. Delayed hypersensitivity to topical corticosteroids. J Am Acad Dermatol 1986; 14: 582-589.
13. Robinson GE, Weber J, Griffiths C, Underhill GS, Jeffries DJ, Goldmeir D. Cutaneous adverse reactions to acyclovir: case reports. Genitourin Med 1985; 61: 62-63.
14. Lammintausta K, Mäkelä L, Kalimo K. Rapid systemic valaciclovir reaction subsequent to aciclovir contact allergy. Contact Dermatitis 2001; 45: 181.
15. Proske S, Uter W, Schnuch A, Hartschuh W. Schwere allergische Kontaktdermatitis mit generalisierter Streuung auf Bufexamac unter dem Bild eines "Baboon"-Syndroms. Dtsch Med Wschr 2003; 128: 545-547.
16. Arzneimittelkommission der deutschen Ärzteschaft. Bufexamac: Ein Ekzemtherapeuticum, das selbst häufig allergische Kontaktekzeme hervorruft. Dtsch Ärztebl 2003; 97: B2703.
17. Amon RB, Lis AW, Hanifin JM. Allergic contact dermatitis caused by idoxuridine. Patterns of cross reactivity with other pyrimidine analogues. Arch Dermatol 1975; 111: 1581-1584.
18. Bircher AJ, Hirsbrunner P, Langauer S. Allergic contact dermatitis of the genitals from rubber additives in condoms. Contact Dermatitis 1993; 28: 125-126.
19. DeGroot AC, Baar TJM, Terpstra H, Weyland JW. Contact allergy to moist toilet paper. Contact Dermatitis 1991; 24: 135-136.
20. DeGroot AC. Vesicular dermatitis of the hands secondary to perianal allergic contact dermatitis caused by preservatives in moistened toilet tissues. Contact Dermatitis 1997; 36: 173-174.
21. Young HS, Beck MH. Post-coital dermatitis from methyldibromo glutaronitrile. Contact Dermatitis 2004; 50: 48.
22. Lazarov A. Perianal contact dermatitis caused by nail lacquer allergy. Am J Contact Dermatitis 1999; 10: 43-44.
23. Penagos HG. Contact dermatitis caused by pesticides among banana plantation workers in Panama. Int J Occup Environ Health 2002; 8: 14-18.
24. Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991; 18: 176-179.
25. Stafford MK, Ward H, Flanagan A, Rosenstein IJ, Taylor-Robinson D, Smith JR, Weber J, Kitchen VS. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 327-331.
26. Rongioletti F, Rivara G, Rebora A. Contact dermatitis to a copper-containing intra-uterine device. Contact Dermatitis 1985; 13: 343.
27. Kint B, Degreef H, Dooms-Goossens A. Combined allergy to human seminal plasma and latex: case report and review of the literature. Contact Dermatitis 1994; 30: 7-11.
28. Fischer G, Ayer B, Frankum B, Spurrett B. Vulvitis attributed to hypersensitivity to estrogen. A report of 11 cases. J Reprod Med 2000; 45: 493-497.
29. Boit R, Manns S, Hartmann M. Spermaallergie - zwei Kasuistiken. Dermatologie in Beruf und Umwelt 2004; 52: 33-35.
30. Guillet G, Dagregorio G. Seminal fluid as a missed allergen in vulvar allergic contact dermatitis. Contact Dermatitis 2004; 50: 318-320.
31. Jacob S, Leveque J, Dugast J, Minoui P, Delaval M, Grall JY. Gynecologic allergy to spermatic fluid. A case report. J Gynecol Obstet Biol Reprod 1997; 26: 825-827.
32. Ludman BG. Humal seminal plasma protein allergy: a diagnosis rarely considered. J Obstet Gynecol Neonatal Nurs 1999; 28: 359-363.
33. Lubbe J, Valiton A, Pedrazetti P, Arechalde A, Harms M. Vulvodynia and facticious urticaria. Ann Dermatol Venereol 2000; 127: 377-379.
34. Placucci F, Lorenzi S, La Placa M, Vincenzi C. Sensitization to benzocaine on a condom. Contact Dermatitis 1996; 34: 293.
35. Bangard C, Rösener I, Merk HF, Baron JM. Typ-I-Sensibilisierung gegenüber Spermaflüssigkeit. Urtikaria und Angioödem. Hautarzt 2004; 55: 79-81.
36. Corey L, Benedetti J, Critchlow C, Mertz G, Douglas J, Fife K, Fahnlander A, Remington ML, Winter C, Dragavon J. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983; 12: 79-88.
37. Gola M, Francalanci S, Brusi C, Lombardi P, Sertoli A. Contact sensitization to acyclovir. Contact Dermatitis 1989; 20: 394-395.
38. Lee JY, Wang BJ. Contact dermatitis caused by cetrimide in antiseptics. Contact Dermatitis 1995; 33: 168-171.
39. Kero M, Hannuksela M, Sothman A. Primary irritant dermatitis from topical clioquinol. Contact Dermatitis 1979; 5: 115-117.
40. Birley HD, Walker MM, Luzzi GA, Bell R, Taylor-Robinson D, Byrne M, Renton AM. Clinical features and management of recurrent balanitis; association with atopy and genital washing. Genitourin Med 1993; 69: 400-403.
41. Eason EL, Feldmann P. Contact dermatitis associated with the use of Always sanitary napkins. CMAJ 1996; 154: 1173-1176.
42. Agner T, Damm P, Skoubry SO. Menstrual cycle and skin reactivity. J Am Acad Dermatol 1991; 24: 566-570.
43. Jordan WP Jr. Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems. Am J Contact Dermal 1997; 8: 108-113.
44. Fischer GO. Vulval disease in prepubertal girls. Australas J Dermatol 2001; 42: 225-234.
45. Fischer G, Rogers M. Vulvar disease in children: a clinical audit of 130 cases. Pediatr Dermatol 2000; 17: 1-6.
46. Herbst RA. Perineal streptococcal dermatitis/disease. Recognition and Management. Am J Clin Dermatol 2003; 4: 555-560.
47. O'Brien TJ. Paediatric vulvovaginitis. Australas J Dermatol 1995; 36: 216-218.
48. Petersen CS. Lack of contact allergy in consecutive women with vulvodynia. Contact Dermatitis 1997; 37: 46-47.